DK2661308T3 - Hypotonisk vandig sammensætning med reduceret chloridindhold med eller uden phospholipider - Google Patents

Hypotonisk vandig sammensætning med reduceret chloridindhold med eller uden phospholipider Download PDF

Info

Publication number
DK2661308T3
DK2661308T3 DK12701434.8T DK12701434T DK2661308T3 DK 2661308 T3 DK2661308 T3 DK 2661308T3 DK 12701434 T DK12701434 T DK 12701434T DK 2661308 T3 DK2661308 T3 DK 2661308T3
Authority
DK
Denmark
Prior art keywords
phosphopholipids
aqueous composition
chloride content
reduced chloride
hypotonic aqueous
Prior art date
Application number
DK12701434.8T
Other languages
English (en)
Inventor
Michael Tchirikov
Original Assignee
Prenatal Int Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prenatal Int Gmbh filed Critical Prenatal Int Gmbh
Application granted granted Critical
Publication of DK2661308T3 publication Critical patent/DK2661308T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK12701434.8T 2011-01-05 2012-01-04 Hypotonisk vandig sammensætning med reduceret chloridindhold med eller uden phospholipider DK2661308T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11000044 2011-01-05
PCT/EP2012/000029 WO2012093087A1 (de) 2011-01-05 2012-01-04 Hypotone wässrige zusammensetzung mit verringertem chloridgehalt mit oder ohne phospholipide

Publications (1)

Publication Number Publication Date
DK2661308T3 true DK2661308T3 (da) 2019-08-12

Family

ID=43982252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12701434.8T DK2661308T3 (da) 2011-01-05 2012-01-04 Hypotonisk vandig sammensætning med reduceret chloridindhold med eller uden phospholipider

Country Status (13)

Country Link
US (2) US9072755B2 (da)
EP (1) EP2661308B1 (da)
CN (1) CN103347566A (da)
DK (1) DK2661308T3 (da)
EA (1) EA027317B1 (da)
ES (1) ES2738914T3 (da)
HR (1) HRP20191387T1 (da)
HU (1) HUE045638T2 (da)
PL (1) PL2661308T3 (da)
PT (1) PT2661308T (da)
RS (1) RS59060B1 (da)
TR (1) TR201911076T4 (da)
WO (1) WO2012093087A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201911076T4 (tr) * 2011-01-05 2019-08-21 Prenatal Int Gmbh Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim.
AU2016256979B2 (en) * 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles
AU2016349390A1 (en) 2015-11-06 2018-05-10 Amnion Life, LLC Premature infant amniotic bath incubator
DE112017007295A5 (de) 2017-03-21 2020-01-02 Universitätsklinikum Halle (Saale) Künstliches Gebärmuttersystem und Plazenta
EP3694518A1 (en) * 2017-10-12 2020-08-19 Novartis AG Combinations of mdm2 inhibitors with inhibitors of erk for treating cancers
WO2019139914A1 (en) 2018-01-09 2019-07-18 Amnion Life, LLC Systems, methods, and devices for artificial placentas and amniotic bed incubators
IL277469B2 (en) 2018-03-29 2024-11-01 Airway Therapeutics Inc Systems and methods for characterizing surfactant protein d (sp-d) oligomers
JP7797098B2 (ja) * 2018-03-29 2026-01-13 エアウェイ・セラピューティクス・インコーポレイテッド サーファクタントタンパク質d(sp-d)を含む方法及び組成物
DE102018126634A1 (de) 2018-10-25 2020-04-30 Prenatal International GmbH Halle Vorrichtung mit künstlichem Kiemensystem und Verfahren für die Lebenserhaltung eines Neugeborenen
EP4062919A1 (de) 2021-03-24 2022-09-28 Prenatal International GmbH Eine oder mehrere zusammensetzungen auf basis des menschlichen fruchtwassers zur anwendung in einem verfahren zur enteralen ernährung, zur enteralen ernährungsergänzung und/oder zur behandlung und/oder versorgung von kapillararmen schichten
US12419763B2 (en) 2023-06-07 2025-09-23 Muhammad TAQI Osmolar devices and methods for preventing tissue swelling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
DE10359867A1 (de) 2003-12-18 2005-07-14 Endress + Hauser Gmbh + Co. Kg Einkopplung
DE602005023127D1 (de) * 2004-02-27 2010-10-07 Nihon Trim Co Ltd Künstliche physiologische salzlösung und verfahren zu ihrer herstellung
DE102010023438A1 (de) 2010-06-11 2011-12-15 Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Ballonkathetersystem zur Ableitung von Flüssigkeiten aus Hohlorganen, Körperhöhlen oder Zysten und/oder zur Zuleitung von Medikamenten
TR201911076T4 (tr) * 2011-01-05 2019-08-21 Prenatal Int Gmbh Klorür içeriği azaltılmış fosfolipit içeren veya içermeyen hipotonik sulu bileşim.

Also Published As

Publication number Publication date
ES2738914T3 (es) 2020-01-27
PT2661308T (pt) 2019-07-31
HUE045638T2 (hu) 2020-01-28
EA201391006A1 (ru) 2013-11-29
TR201911076T4 (tr) 2019-08-21
US9682128B2 (en) 2017-06-20
US20150343027A1 (en) 2015-12-03
US9072755B2 (en) 2015-07-07
HRP20191387T1 (hr) 2019-11-01
EP2661308B1 (de) 2019-05-08
PL2661308T3 (pl) 2019-10-31
WO2012093087A1 (de) 2012-07-12
CN103347566A (zh) 2013-10-09
US20130316980A1 (en) 2013-11-28
EA027317B1 (ru) 2017-07-31
EP2661308A1 (de) 2013-11-13
RS59060B1 (sr) 2019-08-30

Similar Documents

Publication Publication Date Title
DK2661308T3 (da) Hypotonisk vandig sammensætning med reduceret chloridindhold med eller uden phospholipider
LT2775868T (lt) Rūkymo gaminys su matomu turiniu
DK3195793T3 (da) Forbedringer i eller relateret til oftalmologi
DK2793965T3 (da) Vævsprodukter med flydeevne
PL2719190T3 (pl) Dostarczanie treści segmentowanej przestrzennie
DK3590358T3 (da) Næringsmiddelsammensætning
IL232257A0 (en) Personal aircraft
EP2724557A4 (en) PROVISION OF RELEVANT CONTENT
LT2912948T (lt) Porcijos kapsulė gėrimo ruošimui
EP2787837A4 (en) COMMONLY DECOMPOSED STABILIZER COMPOSITION
EP2705844A4 (en) FOOD COMPOSITION
DK3421470T3 (da) Substituerede 5-fluor-1h-pyrazolopyridiner i krytallinsk form
DK3466930T3 (da) Fødevareprodukt med reduceret natriumindhold
CL2015000425A1 (es) Composición alimenticia acuosa enriquecida en beta-glucano
ES2579990T8 (es) Métodos y composiciones para tratar el síndrome metabólico
BR112013033100A2 (pt) materiais anfólitos biomiméticos e biocompatíveis
IL232657A0 (en) Hall effect theruster
BR112014009963A2 (pt) composição dietética
DK2931822T3 (da) Epoxycoatinger med højt faststofindhold
BR112014013218A2 (pt) composição para prolongar a vida útil de produtos frescos
PT2690973T (pt) Composições nutricionais possuindo teor de sódio reduzido e métodos para preparar as mesmas
PL2726442T5 (pl) Modyfikowane aminokarboksylany o ulepszonej trwałości podczas przechowywania i podatność na obróbkę
IL229956B (en) Mphosphi peptides and vaccines including the same
FI10124U1 (fi) Pakkaus beeta-D-glukaanin pitoisuuden määrittämiseksi
BR112014000533A2 (pt) composição comestível